A case in which the subject was affected by Listeia meningoencephalitis during administration of infliximab for steroid-dependent adult onset Still's disease

Japanese Journal of Clinical Immunology

Volumn 29, Issue 3, 2006, Pages 160-168

  Yamamoto, Motohisa ^a   Takahashi, Hiroki ^a   Miamoto, Chie ^a   Ohara, Mikiko ^a   Suzuki, Chisako ^a   Naishiro, Yasuyoshi ^a   Yamamoto, Hiroyuki ^a   Shinomura, Yasuhisa ^a   Nonaka, Michiononaka ^a   Imai, Kohzoh ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adult onset Still's disease; Glucocorticoid; Infliximab; Listeria monocytogenes; Meningoencephalitis

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; ANTIRHEUMATIC AGENT; DEXAMETHASONE; INFLIXIMAB; MEROPENEM; MONOCLONAL ANTIBODY; THIENAMYCIN DERIVATIVE;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; REMISSION;

ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DEXAMETHASONE; FEMALE; HUMANS; MENINGITIS, LISTERIA; REMISSION INDUCTION; STILL'S DISEASE, ADULT-ONSET; THIENAMYCINS;

EID: 33748116187     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.29.160     Document Type: Article

References (34)

1. Maini RN, et al.: Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum. 41: 1552–1563, 1998.
2. Tamesis ER, et al.: Etanercept in recalcitrant adult onset Still's disease (AOSD). Arthritis Rheum. 43: S229, 2000.
3. Cavagna L, et al.: Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol. 19: 329–332, 2001.
4. Kraetsch HG, et al.: Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: First experiences. Ann Rheum Dis. 60 (Suppl 3): Iii55–iii57, 2001.
5. Husni ME, et al.: Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum. 46: 1171–1176, 2002.
6. Fautrel B, et al.: Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: An observational study of 20 cases. Ann Rheum Dis. 64: 262–266, 2005.
7. Keane J: TNF-blockade agents ant tuberculosis: New drugs illuminate an old topic. Rheumatology (Oxford). 44: 714–720, 2005.
8. Carmona L, et al.: Effectiveness of recommendation to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum. 52: 1766–1772, 2005.
9. Crum NF, Lederman ER, Wallace MR: Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore). 84: 291–302, 2005.
10. Goulet V, Marchetti P: Listeriosis in 225 non-pregnant patients in 1992: Clinical aspects and outcome in relation to predisposing conditions. Scand J Infect Dis. 28: 367–374, 1996.
11. Cone LA, et al.: Multiple cerebral abscesses because of Listeria monocytogenes: Three cases reports and a literature review of supratentorial listerial brain abscess (es). Surg Neurol. 59: 320–328, 2003.
12. Yamaguchi M, et al.: Preliminary criteria for classification of adult Still's disease. J Rheumatol. 19: 424–430, 1992.
13. Nishibori T, et al.: Correlation between the presence of virulence-associated genes as determined by PCR and actual virulence to mice in various strains of Listeria spp. Microbiol Immunol. 39: 343–349, 1995.
14. Jaradat ZW, et al.: Genietic homogeneity among Listeria monocytogenes strains from infected patients and meat products from two geographic locations determined by phenotyping, ribotyping and PCR analysis of virulence genes. Int J Food Microbiol. 76: 1–10, 2002.
15. Poros-Gluchowska J, Markiewicz Z: Antimicrobial resistance of Listeria monocytogenes. Acta Microbiol Pol. 52: 113–129, 2003.
16. Temple ME, Nahata MC: Treatment of listeriosis. Ann Pharmacother. 34: 656–661, 2000.
17. Hof H, Nichterlein T, Kretschmar M: Management of listeriosis. Clin Microbiol Rev. 10: 345–357, 1997.
18. Weston VC, et al: Listeria monocytogenes meningitis in a penicillin-allergic paediatric renal transplant patient. J Infect. 37: 77–78, 1998. 162–165, 2004.
19. Stamm AM: Listeriosis. Bennett JC, Plum F, ed., Textbook of Medicine, 20th ed. WB Saunders, Philadelphia, pp 1672–1673, 1996.
20. Seeliger HPR, Hohne K: Serotypeing of Listeria monocytogenes and related species. Methods Microbiol. 13: 31–49, 1979.
21. McLauchlin J: Distribution of serovars of Listeria monocytogenes isolated from different categories of patients with listeriosis. Eur J Clin Microbiol Infect Dis. 9: 210–213, 1990.
22. Glaser P, et al: Comparative genomics of Listeria species. Science 294: 849–852, 2001.
23. Jensen VB, Harty JT, Jones BD: Interactions of the invasive pathgens Salmonella typhimurium, Listeria monocytogenes,and Shigella flexneri with M cells and murine Peyer's patches. Infect Immun. 66: 3758–3766, 1998.
24. Ehlers S: Role of tumour necrosis factor (TNF) in host defence against tuberculosis: Implications for immunotherapies targeting TNF. Ann Rheum Dis. 62 (Suppl 2): Ii37, 2003.
25. Slifman NR, et al.: Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α-neutralizing agents. Arthritis Rheum. 48: 319–324, 2003.
26. Gluck T, et al.: Anti-tumor necrosis factor thrapy and Listeria monocytogenes infection: Report of two cases. Arthritis Rheum. 46: 2255–2257, 2002.
27. Aparicio AG, et al.: Report of an additional case of anti-tumor necrosis factor thrapy and Listeria monocytogenes infection: Comment on the letter by Gluck et al. Arthritis and Rheum. 48: 1764–1766, 2003.
28. Bowie VL, et al.: Listeria meningitis associated with inliximab. Ann Pharmacother. 38: 58–61, 2004.
29. Pagliano P, et al.: Does etanercept monotherapy enhance the risk of Listeria monocytogenes meningitis? Ann Rheum Dis. 63: 462–463, 2004.
30. Rachapalli S, O’Daunt S: Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept. Arthritis Rheum. 52: 987, 2005.
31. La Montagna G, Valentini G: Listeria monocytogenes meningitis in a patient receiving etanercept for Still's disease. Clin Exp Rheumatol. 23: 121, 2005.
32. Schett G, et al.: Listeria-associated arthritis in a patient undergoing etanercept therapy: Case report and review of the literature. J Clin Microbiol. 43: 2537–2541, 2005.
33. Levitz RE, Quintiliani R: Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Intern Med. 100: 881–890, 1984.
34. Ramanan AV, Schneider R: Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol. 30: 4011–403, 2003.